Journal of Toxicology / 2013 / Article / Tab 2

Clinical Study

Analysis of Safety from a Human Clinical Trial with Pterostilbene

Table 2

Self-reported adverse drug reactions (ADRs)a.

ADRs reported (%) value
(versus placebo)
Type of ADR (#)

Any pterostilbene6010 (16.7)0.72

High-dose pterostilbene205 (25)0.42Gastrointestinal (2)
Increased appetite (2)
Itching (1)
Low-dose pterostilbene203 (15)1.00Muscle pain (2)
Increased appetite (1)
Low-dose + grape extract202 (10)1.00Muscle pain (1)
Increased appetite (1)

Placebo202 (10)Gastrointestinal (1)
Itching (1)

aIntention-to-treat population evaluated.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.